YELENA RAZGONYAYEVA: Open Payments
NPI 1487275467 · MISSION HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 68 payments from 12 companies in 2025. Trend: 2023 $1,201 · 2024 $1,259 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 12 | $694 |
| Novartis Pharmaceuticals Corporation | 17 | $336 |
| UCB, Inc. | 11 | $327 |
| ABBVIE INC. | 7 | $240 |
| Boston Scientific Corporation | 4 | $114 |
| GENZYME CORPORATION | 3 | $102 |
| LEO Pharma Inc. | 4 | $99 |
| Incyte Corporation | 4 | $85 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Botanix SB Inc | 2 | $47 |
Products named: NEMLUVIO, Bimzelx, COSENTYX, DUPIXENT, BOTOX, General - Pain Management, OPZELURA, SKYRIZI.
Industry payments across CA — which companies pay providers there.
